Aamer Aleem1, Faisal Alsayegh2, Satish Keshav3, Abdulrahman Alfadda4, Ahmad Awad Alfadhli5, Abdulrahman Al-Jebreen6, Fawaz Al-Kasim7, Ali Almuhaini8, Hazzaa Al-Zahrani9, Faisal Batwa10, Srdjan Denic11, Ahmad Jazzar12, Tarek Owaidah13, Mohamad Qari14, Yousef Qari15, Mazen Taha16. 1. Department of Medicine, Division of Hematology/Oncology, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia, ameralem@ksu.edu.sa. 2. Department of Medicine, Faculty of Medicine, Health Sciences Center, Kuwait University, Jabriya, Kuwait. 3. Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom. 4. Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. 5. Gastroenterology and Hepatology Center, Mubarak Al-Kabeer Hospital, Jabriya, Kuwait. 6. Department of Medicine, Division of Gastroenterology, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia. 7. Department of Pediatric Hematology/Oncology, Children Hospital, King Saud Medical City, Riyadh, Saudi Arabia. 8. Department of Internal Medicine, Division of Clinical Hematology, Mubarak Al-Kabeer Hospital, Jabriya, Kuwait. 9. King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. 10. King Khaled National Guard Hospital, Jeddah, Saudi Arabia. 11. Department of Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates. 12. Gastroenterology Section, Gulf Diagnostic Center Hospital, Abu Dhabi, United Arab Emirates. 13. King Faisal Specialist Hospital and Research Center, Alfaisal University, Riyadh, Saudi Arabia. 14. Hematology Department, Faculty of Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia. 15. King Abdulaziz University Hospital, Jeddah, Saudi Arabia. 16. Department of Medicine, Division of Gastroenterology/Hepatology, Tawam Hospital, Al Ain, United Arab Emirates.
Abstract
BACKGROUND: Iron deficiency (ID) and ID anemia (IDA) are common in the member states of the Gulf Cooperation Council (GCC). The unique genetic and lifestyle factors of the patient population in the region have necessitated the development of recommendations to help educate health-care professionals on appropriate diagnosis and management of ID/IDA. METHODS: A panel of regional experts, including gastroenterologists and hematologists with expertise in the treatment of IDA, was convened to develop regional practice recommendations for ID/IDA. After reviewing the regional and international literature, the expert panel developed consensus recommendations for screening, diagnosis, and treatment of patients with IDA in the GCC region. RESULTS: The recommendations proposed were customized to the patient population keeping in view the increasingly recognized burden of coeliac disease, high fertility and obesity rates, high prevalence of alpha- and beta-thalassemia traits, and poor tolerance and low treatment compliance with oral iron therapy. CONCLUSIONS: This consensus statement proposes recommendations for screening, diagnosis, and treatment of IDA in the GCC region.
BACKGROUND: Iron deficiency (ID) and ID anemia (IDA) are common in the member states of the Gulf Cooperation Council (GCC). The unique genetic and lifestyle factors of the patient population in the region have necessitated the development of recommendations to help educate health-care professionals on appropriate diagnosis and management of ID/IDA. METHODS: A panel of regional experts, including gastroenterologists and hematologists with expertise in the treatment of IDA, was convened to develop regional practice recommendations for ID/IDA. After reviewing the regional and international literature, the expert panel developed consensus recommendations for screening, diagnosis, and treatment of patients with IDA in the GCC region. RESULTS: The recommendations proposed were customized to the patient population keeping in view the increasingly recognized burden of coeliac disease, high fertility and obesity rates, high prevalence of alpha- and beta-thalassemia traits, and poor tolerance and low treatment compliance with oral iron therapy. CONCLUSIONS: This consensus statement proposes recommendations for screening, diagnosis, and treatment of IDA in the GCC region.
Authors: Kassem Barada; Abbas Bitar; Mohamad Abdul-Razak Mokadem; Jana Ghazi Hashash; Peter Green Journal: World J Gastroenterol Date: 2010-03-28 Impact factor: 5.742
Authors: Axel U Dignass; Christoph Gasche; Dominik Bettenworth; Gunnar Birgegård; Silvio Danese; Javier P Gisbert; Fernando Gomollon; Tariq Iqbal; Konstantinos Katsanos; Ioannis Koutroubakis; Fernando Magro; Guillaume Savoye; Jürgen Stein; Stephan Vavricka Journal: J Crohns Colitis Date: 2014-12-03 Impact factor: 9.071
Authors: Diego Moretti; Jeroen S Goede; Christophe Zeder; Markus Jiskra; Vaiya Chatzinakou; Harold Tjalsma; Alida Melse-Boonstra; Gary Brittenham; Dorine W Swinkels; Michael B Zimmermann Journal: Blood Date: 2015-08-19 Impact factor: 22.113
Authors: Jane E Onken; David B Bregman; Robert A Harrington; David Morris; Peter Acs; Bruce Akright; Charles Barish; Birbal S Bhaskar; Gioi N Smith-Nguyen; Angelia Butcher; Todd A Koch; Lawrence T Goodnough Journal: Transfusion Date: 2013-06-17 Impact factor: 3.157
Authors: Walter Reinisch; Michael Staun; Rakesh K Tandon; Istvan Altorjay; Andrew V Thillainayagam; Cornelia Gratzer; Sandeep Nijhawan; Lars L Thomsen Journal: Am J Gastroenterol Date: 2013-10-22 Impact factor: 10.864
Authors: Mohammad S Akhter; Hassan A Hamali; Johar Iqbal; Abdullah A Mobarki; Hina Rashid; Gasim Dobie; Aymen M Madkhali; Bader Y H Arishi; Emad O O Ageeli; Osama S H Laghbi Journal: Int J Environ Res Public Health Date: 2021-12-07 Impact factor: 3.390